萨尔科马免疫微环境中的亡:从生物学到治疗
Huali Ye1, Minxun Lu1, Chongqi Tu1
1Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China.
International immunopharmacology
|July 19, 2023
概括
细胞亡,一个被编程的细胞死亡,提供了一个新的策略来对抗抗细胞亡耐药的肉瘤. 这种细胞死亡途径显示出对瘤治疗和与免疫疗法结合治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞死亡研究 细胞死亡研究
背景情况:
- 抗亡是瘤治疗失败的一个关键挑战.
- 亡,一种独特的编程细胞死亡,被探索为克服抵抗的替代方案.
- 在瘤微环境的免疫反应和癌症的发展中死细胞的作用正在调查中.
研究的目的:
- 审查瘤免疫微环境和肉瘤进展中的亡的双重作用.
- 探索 Sarcoma 中向死细胞的治疗潜力.
- 评估亡作为一种与免疫疗法协同治疗肉瘤的策略.
主要方法:
- 关于亡机制及其在癌症中的作用的文献综述.
- 在肉瘤预后和治疗反应中分析与亡相关的分子.
- 探索诱导亡作为一种治疗策略.
主要成果:
- 亡是由RIPK和MLKL蛋白质调解的,在形态上类似于亡.
- 亡可以在瘤微环境中产生亲瘤或抗瘤效应.
- 与亡相关的分子对于预测肉瘤预后和治疗结果非常有价值.
结论:
- 亡是一种有前途的治疗标,用于克服肉瘤中亡抵抗.
- 诱导亡可能是治疗肉瘤的可行策略,可能提高免疫疗法的疗效.
- 对亡调节的进一步研究可能会导致新的肉瘤治疗方法.
相关概念视频
01:27Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K